Paul A. LaViolette, MBA

Paul A. LaViolette, MBA
Chief Operating Officer, Boston Scientific Corporation, Natick, MA; Member, Board of Directors, and Chairman, Special Committee on Codes of Ethics, AdvaMed

Correspondence: Paul A. LaViolette, Chief Operating Officer, Boston Scientific Corporation, One Boston Scientific Place, Natick, MA 01760; [email protected]

Acknowledgment: The author is indebted to two individuals for their contributions to concepts discussed in this article: Donald S. Baim, MD, of Boston Scientific, and Christopher L. White of AdvaMed. Dr. Baim has coauthored a manuscript on this topic entitled “Medical Device Development: A Balanced Approach to Managing Conflicts of Interest Encountered by Physicians,” resulting in part from the 3rd Dartmouth Device Development Symposium (3D3), October 27 and 28, 2005.

Mr. LaViolette reported that he has no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article apart from his employment with Boston Scientific Corp., from which he receives a salary and in which he holds ownership interest.

Paul A. LaViolette, MBA
Chief Operating Officer, Boston Scientific Corporation, Natick, MA; Member, Board of Directors, and Chairman, Special Committee on Codes of Ethics, AdvaMed

Correspondence: Paul A. LaViolette, Chief Operating Officer, Boston Scientific Corporation, One Boston Scientific Place, Natick, MA 01760; [email protected]

Acknowledgment: The author is indebted to two individuals for their contributions to concepts discussed in this article: Donald S. Baim, MD, of Boston Scientific, and Christopher L. White of AdvaMed. Dr. Baim has coauthored a manuscript on this topic entitled “Medical Device Development: A Balanced Approach to Managing Conflicts of Interest Encountered by Physicians,” resulting in part from the 3rd Dartmouth Device Development Symposium (3D3), October 27 and 28, 2005.

Mr. LaViolette reported that he has no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article apart from his employment with Boston Scientific Corp., from which he receives a salary and in which he holds ownership interest.

Paul A. LaViolette, MBA
Chief Operating Officer, Boston Scientific Corporation, Natick, MA; Member, Board of Directors, and Chairman, Special Committee on Codes of Ethics, AdvaMed

Correspondence: Paul A. LaViolette, Chief Operating Officer, Boston Scientific Corporation, One Boston Scientific Place, Natick, MA 01760; [email protected]

Acknowledgment: The author is indebted to two individuals for their contributions to concepts discussed in this article: Donald S. Baim, MD, of Boston Scientific, and Christopher L. White of AdvaMed. Dr. Baim has coauthored a manuscript on this topic entitled “Medical Device Development: A Balanced Approach to Managing Conflicts of Interest Encountered by Physicians,” resulting in part from the 3rd Dartmouth Device Development Symposium (3D3), October 27 and 28, 2005.

Mr. LaViolette reported that he has no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article apart from his employment with Boston Scientific Corp., from which he receives a salary and in which he holds ownership interest.

Moderator
Nina Totenberg
Legal Affairs Correspondent, National Public Radio, Washington, DC

Panelists
Darrell G. Kirch, MD
President and CEO, Association of American Medical Colleges, Washington, DC

Paul A. LaViolette, MBA
Chief Operating Officer, Boston Scientific Corporation, Natick, MA; Member, Board of Directors, and Chairman, Special Committee on Codes of Ethics, AdvaMed

Norka Ruiz Bravo, PhD
Deputy Director for Extramural Research, National Institutes of Health, Bethesda, MD

Mr. LaViolette reported that he has no financial interests or relationships that pose a potential conflict of interest with this article apart from his employment with Boston Scientific Corp., from which he receives a salary and in which he holds ownership interest.

All other participants reported that they have no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article.

Moderator
Nina Totenberg
Legal Affairs Correspondent, National Public Radio, Washington, DC

Panelists
Darrell G. Kirch, MD
President and CEO, Association of American Medical Colleges, Washington, DC

Paul A. LaViolette, MBA
Chief Operating Officer, Boston Scientific Corporation, Natick, MA; Member, Board of Directors, and Chairman, Special Committee on Codes of Ethics, AdvaMed

Norka Ruiz Bravo, PhD
Deputy Director for Extramural Research, National Institutes of Health, Bethesda, MD

Mr. LaViolette reported that he has no financial interests or relationships that pose a potential conflict of interest with this article apart from his employment with Boston Scientific Corp., from which he receives a salary and in which he holds ownership interest.

All other participants reported that they have no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article.

Moderator
Nina Totenberg
Legal Affairs Correspondent, National Public Radio, Washington, DC

Panelists
Darrell G. Kirch, MD
President and CEO, Association of American Medical Colleges, Washington, DC

Paul A. LaViolette, MBA
Chief Operating Officer, Boston Scientific Corporation, Natick, MA; Member, Board of Directors, and Chairman, Special Committee on Codes of Ethics, AdvaMed

Norka Ruiz Bravo, PhD
Deputy Director for Extramural Research, National Institutes of Health, Bethesda, MD

Mr. LaViolette reported that he has no financial interests or relationships that pose a potential conflict of interest with this article apart from his employment with Boston Scientific Corp., from which he receives a salary and in which he holds ownership interest.

All other participants reported that they have no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article.